Companies Corona Virus Indian Subcontinent Life Science Life Style medical

BharatBiotech says Covaxin is to be administered subject to Conditions apply clauses

The move to include Covaxin even before the publication of data from its phase 3 trial had come under criticism from some quarters.   However, the regulator had defended the decision by saying that both the vaccines were totally safe.   Over 500 adverse reactions were reported from across the country during two days of Read More…

Corona Virus Indian Subcontinent Life Science medical

Indians so far 3.8 lakhs vaccinated and 580 found adverse effect : Health Ministry

In india a total of 3,81,305 beneficiaries have so far been vaccinated for coronavirus, even as 580 adverse events following immunization were reported in the country, the Union Health Ministry said on Monday.   Yesterday, for the first time, active cases declined below 2 per cent of the total cases reported in the country.   Read More…

Corona Virus Indian Subcontinent Life Science

Covid-19 Phase 1 vaccination will kick-off on January 16 across India

The much-awaited Covid-19 vaccination drive will kick-off on January 16. Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively.   “As many as Read More…

ADMK BJP Cinema Entertainment Protest South India

Center Quotes SC order and send letter to Tamilnadu Government to revoke 100% seating in cinemas

The BJP led Modi government ’s  Union Home ministry on Wednesday, asked the  ADMK led Palanisamy Tamil Nadu government to revoke its order allowing 100% seating in cinemas from the current 50% capacity.  Centre  has categorically said that state government’s decision diluted the guidelines issued by the Union ministry of home affairs (MHA).   The Read More…

Corona Virus Indian Subcontinent Industries Life Science medical

Bharat Biotech’s vaccine also got approval for roll-out of COVID-19 shots

The recommendation for Bharat Biotech’s vaccine came a day after the panel cleared the Serum Institute of India’s emergency use athorisation application for the Oxford-AstraZeneca vaccine Covishield, paving the way for the roll-out of COVID-19 shots in the country in the next few days. The Union Health Ministry on Saturday also confirmed that the Subject Read More…

Companies Corona Virus Indian Subcontinent Industries Life Science

Expert Committee of India’s Drug approved emergency use of vaccine “Covishield”

The 10-member Subject Expert Committee of India’s Central Drug Standard Control Organisation on Friday approved emergency use authorisation of the Oxford-AstraZeneca coronavirus vaccine ‘Covishield’.   The expert panel had convened a meeting to take a call on the emergency use authorisation sought by the Serum Institute of India, the manufacturer of Covishield, and Bharat Biotech Read More…

Corona Virus World

WHO chief Tedros warns covid-19 crisis is not the last pandemic

World Health Organizations (WHO) chief Tedros Adhanom Ghebreyesus on Saturday (December 26) said that the COVID-19 crisis will not be the last pandemic and all steps taken to improve human health are “doomed” if the global community fails to tackle climate change and animal welfare.   In a video message marking Sunday’s first International Day Read More…

Corona Virus Europe Life Science medical

UK four volunteers who were administered Pfizer vaccine developed Bell’s palsy

United Kingdom started inoculating people with the coronavirus vaccine developed by Pfizer-BioNTech.   In that exercise In United kingdom  developed Bell’s palsy, according to US Food and Drug Administration (FDA) regulators.   Medically Bell’s palsy means is a form of temporary facial paralysis.   THe person suffering from Bell’s palsy develops temporary weakness or paralysis Read More…

Corona Virus Life Science medical Voice

Aggrieved Volunteer who has taken SSI vaccine to Knock Court Door

The 40-year-old Chennai volunteer, who had earlier sent a legal notice to the Pune-based Serum Institute of India (SII) against its Covishield vaccine trial, has decided to move court. Earlier, he had sent a legal notice seeking ~5 crore in damages, alleging he had developed severe neurological complications and impaired cognitive functions after he took Read More…